Sandi See Tai's most recent trade in Lexeo Therapeutics Inc. was a trade of 386 Common Stock done at an average price of $9.3 . Disclosure was reported to the exchange on Nov. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 18 Nov 2025 | 386 | 65,476 | - | 9.3 | 3,578 | Common Stock | |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 15 Oct 2025 | 10,890 | 69,750 | - | 0 | Common Stock | ||
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 15 Oct 2025 | 3,844 | 65,906 | - | 8.9 | 34,346 | Common Stock | |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 15 Oct 2025 | 44 | 65,862 | - | 9.6 | 421 | Common Stock | |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 18 Aug 2025 | 382 | 58,860 | - | 4.7 | 1,783 | Common Stock | |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 16 May 2025 | 367 | 59,242 | - | 2.8 | 1,018 | Common Stock | |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 14 Mar 2025 | 5,720 | 59,609 | - | 2.6 | 14,929 | Common Stock | |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 19 Feb 2025 | 1,486 | 53,889 | - | 4.4 | 6,558 | Common Stock | |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 07 Jan 2025 | 77,500 | 77,500 | - | - | Stock Option (right to buy) | ||
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 07 Jan 2025 | 38,750 | 55,375 | - | 0 | Common Stock |